arrow
K

Kamala Thriemer

Menzies School of Health Research
H指数:40
被引数:4,668

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Temporal Changes in the Genetic Diversity and Relatedness of Plasmodium vivax Clinical Infections in Eastern Cambodia

东柬埔寨恶性疟原虫临床感染的遗传多样性和相关性随时间的变化

2026-09-170
OAAI
Dissemination of EFFORT trial results in Indonesia: a stakeholder meeting report on tafenoquine and primaquine for radical cure of Plasmodium vivax

印尼EFFORT试验结果的传播:关于使用阿托喹酮和伯氨喹进行间日疟原虫根治的利益相关者会议报告

2026-05-011
OA
Short-Course Low-Dose Primaquine for Radical Cure in G6PD-Normal Patients in the Pre-Elimination Context of Nepal

短疗程低剂量伯氨喹用于Nepal消除前背景中G6PD正常患者的彻底根治

2026-04-250
OAAI
Systematic review and individual patient data meta-analysis on glucose-6-phosphate dehydrogenase activities measured by a semi-quantitative handheld biosensor

系统评价和基于半定量手持生物传感器测量的葡萄糖-6-磷酸脱氢酶活性的个体患者数据Meta分析

2025-11-200
OAAI
Automated reporting of primaquine dose efficacy, tolerability and safety for Plasmodium vivax malaria using a systematic review and individual patient data meta-analysis

使用系统综述和个体患者数据Meta分析,对伯氨喹剂量在间日疟中的疗效、耐受性和安全性进行自动化报告

2025-11-140
OAAI
Effectiveness of tafenoquine and primaquine for radical cure of Plasmodium vivax: a meeting report from dissemination of results of the EFFORT trial to stakeholders in Pakistan

塔非喹宁和伯氨喹对间日疟原虫根治的有效性:来自巴基斯坦利益相关者传播EFFORT试验结果会议的报告

2025-11-110
OAAI
Perceptions of shorter radical cure Plasmodium vivax treatment regimens and their implementation: a qualitative study among stakeholders in Cambodia

间日疟原虫短疗程根治方案的认知及其实施:柬埔寨利益相关者定性研究

2025-09-300
OAAI
Performance of quantitative point-of-care tests to measure G6PD activity: An individual participant data meta-analysis
2025-03-010
OAAI
Primaquine dose and the risk of haemolysis in patients with uncomplicated Plasmodium vivax malaria: a systematic review and individual patient data meta-analysis

Primaquine剂量和无并发症的间日疟患者的溶血风险: 系统评价和个体患者数据荟萃分析

2024-02-0112
OAAI
Effect of primaquine dose on the risk of recurrence in patients with uncomplicated Plasmodium vivax: a systematic review and individual patient data meta

伯喹剂量对无并发症间日疟患者复发风险的影响: 系统评价和个体患者数据meta

2024-02-0113
OAAI
Safety and efficacy of primaquine in patients with Plasmodium vivax malaria from South Asia: a systematic review and individual patient data meta-analysis

伯喹治疗南亚间日疟患者的安全性和有效性: 系统评价和个体患者数据荟萃分析

2023-12-203
OAAI
Primaquine radical cure in patients with Plasmodium falciparum malaria in areas co-endemic for P falciparum and Plasmodium vivax (PRIMA): a multicentre, open-label, superiority randomised controlled trial
LANCET
IF88.5
2023-12-019
OAAI
Weekly primaquine for radical cure of patients with Plasmodium vivax malaria and glucose-6-phosphate dehydrogenase deficiency
2023-09-066
OAAI
The heterogeneity of symptom reporting across study sites: a secondary analysis of a randomised placebo-controlled multicentre antimalarial trial
2023-09-041
OAAI